LIFEMEL Efficacy in Preventing Haematopoietic Toxicity in Patients Treated With Chemotherapy
NCT04562922
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
39
Enrollment
INDUSTRY
Sponsor class
Conditions
Neutropenia
Adverse Event
Interventions
DIETARY_SUPPLEMENT:
Lifemel
Sponsor
VitalMel